300110 华仁药业
已收盘 10-31 15:00:00
资讯
新帖
简况
华仁药业(300110)10月10日股东户数4.07万户,较上期增加0.26%
证券之星 · 10-30 09:43
华仁药业(300110)10月10日股东户数4.07万户,较上期增加0.26%
图解华仁药业三季报:第三季度单季净利润同比下降22.72%
证券之星 · 10-29 12:37
图解华仁药业三季报:第三季度单季净利润同比下降22.72%
股市必读:华仁药业(300110)股东户数4.07万户,较上期增加0.49%
证券之星 · 10-21
股市必读:华仁药业(300110)股东户数4.07万户,较上期增加0.49%
华仁药业完成补选李健为第八届董事会非独立董事
中金财经 · 10-15
华仁药业完成补选李健为第八届董事会非独立董事
股市必读:10月13日华仁药业发布公告,股东减持328.76万股
证券之星 · 10-13
股市必读:10月13日华仁药业发布公告,股东减持328.76万股
华仁药业:大股东西安曲江天授质押118,221,298股
证券之星 · 10-13
华仁药业:大股东西安曲江天授质押118,221,298股
华仁药业(300110)披露补选第八届董事会非独立董事议案,9月29日股价上涨0.62%
证券之星 · 09-29
华仁药业(300110)披露补选第八届董事会非独立董事议案,9月29日股价上涨0.62%
华仁药业(300110.SZ)参与京津冀“3+N”联盟部分西药和中成药带量联动接续采购中选
智通财经 · 09-29
华仁药业(300110.SZ)参与京津冀“3+N”联盟部分西药和中成药带量联动接续采购中选
华仁药业:截至2025年9月10日股东总户数约为4.11万户
证券之星 · 09-17
华仁药业:截至2025年9月10日股东总户数约为4.11万户
9月9日华仁药业发布公告,股东减持853.24万股
证券之星 · 09-09
9月9日华仁药业发布公告,股东减持853.24万股
华仁药业最新公告:全资子公司安徽恒星制药盐酸奈福泮原料药获得上市申请批准通知书
证券之星 · 09-01
华仁药业最新公告:全资子公司安徽恒星制药盐酸奈福泮原料药获得上市申请批准通知书
华仁药业:董事长张力受监视居住 已推举董事侯瑞鹏代行职责
金融界 · 08-26
华仁药业:董事长张力受监视居住 已推举董事侯瑞鹏代行职责
华仁药业:截至2025年8月20日股东总户数约为4.10万户
证券之星 · 08-22
华仁药业:截至2025年8月20日股东总户数约为4.10万户
华仁药业(300110)2025年中报简析:净利润减49.01%
证券之星 · 08-16
华仁药业(300110)2025年中报简析:净利润减49.01%
华仁药业:截至8月10日股东总户数约为4.15万户
证券之星 · 08-12
华仁药业:截至8月10日股东总户数约为4.15万户
华仁药业:截至2025年7月31日股东总户数约为4.24万户
证券之星 · 08-06
华仁药业:截至2025年7月31日股东总户数约为4.24万户
华仁药业最新公告:持股5%以上股东红塔创新计划减持不超过1%公司股份
证券之星 · 08-03
华仁药业最新公告:持股5%以上股东红塔创新计划减持不超过1%公司股份
华仁药业:截至7月20日股东总户数约为4.16万户
证券之星 · 07-31
华仁药业:截至7月20日股东总户数约为4.16万户
华仁药业(300110.SZ)子公司取得一项医疗器械注册证
智通财经 · 07-30
华仁药业(300110.SZ)子公司取得一项医疗器械注册证
7月16日华仁药业发布公告,股东减持1018.48万股
证券之星 · 07-16
7月16日华仁药业发布公告,股东减持1018.48万股
加载更多
公司概况
公司名称:
华仁药业股份有限公司
所属行业:
医药制造业
上市日期:
2010-08-25
主营业务:
华仁药业股份有限公司的主营业务是医药、医疗器械、医用包材、大健康、医药商业流通。公司的主要产品是基础输液、治疗制剂、腹透液、医疗器械、其他。公司是山东省应急储备定点输液生产企业,先后获得“全国AAA级信用企业”“国家知识产权优势/示范企业”“中国化学制药行业工业企业综合实力百强”“中国医药工业百强”“山东省质量管理奖”“山东省高端品牌培育企业”“‘品质鲁药’建设示范企业”等系列荣誉。
发行价格:
13.99
{"stockData":{"symbol":"300110","market":"SZ","secType":"STK","nameCN":"华仁药业","latestPrice":3.4,"timestamp":1761894234000,"preClose":3.32,"halted":0,"volume":24369200,"delay":0,"changeRate":0.0241,"floatShares":1181000000,"shares":1182000000,"eps":-1.1922,"marketStatus":"已收盘","change":0.08,"latestTime":"10-31 15:00:00","open":3.33,"high":3.41,"low":3.32,"amount":82420400,"amplitude":0.0271,"askPrice":3.4,"askSize":1419,"bidPrice":3.39,"bidSize":5339,"shortable":0,"etf":0,"ttmEps":-1.1922,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1762133400000},"marketStatusCode":5,"adr":0,"adjPreClose":3.32,"symbolType":"stock","openAndCloseTimeList":[[1761874200000,1761881400000],[1761886800000,1761894000000]],"highLimit":3.65,"lowLimit":2.99,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1182212982,"isCdr":false,"pbRate":2.9,"roa":"--","roe":"4.11%","epsLYR":-1.1576,"committee":-0.243068,"marketValue":4020000000,"turnoverRate":0.0206,"status":0,"floatMarketCap":4015000000},"requestUrl":"/m/hq/s/300110","defaultTab":"news","newsList":[{"id":"2579211332","title":"华仁药业(300110)10月10日股东户数4.07万户,较上期增加0.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579211332","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579211332?lang=zh_cn&edition=full","pubTime":"2025-10-30 17:43","pubTimestamp":1761817426,"startTime":"0","endTime":"0","summary":"证券之星消息,近日华仁药业披露,截至2025年10月10日公司股东户数为4.07万户,较9月30日增加105.0户,增幅为0.26%。在化学制药行业个股中,华仁药业股东户数高于行业平均水平,截至10月10日,化学制药行业平均股东户数为3.43万户。从股价来看,2025年9月30日至2025年10月10日,华仁药业区间跌幅为0.0%,在此期间股东户数增加105.0户,增幅为0.26%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000034173.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0102","BK0239"],"gpt_icon":0},{"id":"2579722905","title":"图解华仁药业三季报:第三季度单季净利润同比下降22.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579722905","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579722905?lang=zh_cn&edition=full","pubTime":"2025-10-29 20:37","pubTimestamp":1761741454,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业2025年三季报显示,前三季度公司主营收入9.76亿元,同比下降9.07%;归母净利润5457.98万元,同比下降42.87%;扣非净利润4572.72万元,同比下降49.18%;其中2025年第三季度,公司单季度主营收入3.52亿元,同比上升16.62%;单季度归母净利润1724.69万元,同比下降22.72%;单季度扣非净利润1803.8万元,同比下降18.63%;负债率58.02%,投资收益228.18万元,财务费用3378.4万元,毛利率34.15%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900041781.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110"],"gpt_icon":0},{"id":"2577780258","title":"股市必读:华仁药业(300110)股东户数4.07万户,较上期增加0.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577780258","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577780258?lang=zh_cn&edition=full","pubTime":"2025-10-22 04:21","pubTimestamp":1761078067,"startTime":"0","endTime":"0","summary":"截至2025年10月21日收盘,华仁药业报收于3.38元,上涨3.05%,换手率2.2%,成交量26.04万手,成交额8695.61万元。当日关注点来自交易信息汇总:10月21日主力资金净流入103.93万元,显示主力小幅加仓。股本股东变化股东户数变动近日华仁药业披露,截至2025年10月10日公司股东户数为4.07万户,较9月20日增加200.0户,增幅为0.49%。户均持股数量由上期的2.92万股减少至2.9万股,户均持股市值为9.44万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200004049.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0102","BK0239"],"gpt_icon":0},{"id":"2575178662","title":"华仁药业完成补选李健为第八届董事会非独立董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2575178662","media":"中金财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575178662?lang=zh_cn&edition=full","pubTime":"2025-10-15 19:05","pubTimestamp":1760526307,"startTime":"0","endTime":"0","summary":"中访网数据 华仁药业股份有限公司于2025年10月15日召开2025年第二次临时股东大会,审议通过了关于补选李健先生为公司第八届董事会非独立董事的议案。李健先生的任期自本次股东大会审议通过之日起,至公司第八届董事会任期届满之日止。此次人事变动后,公司董事会中兼任高级管理人员及由职工代表担任的董事总数符合不超过董事会成员二分之一的监管要求。李健先生现任华仁药业董事、总裁,具有医学博士学历及副主任医师职称,拥有丰富的医疗及管理经验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251015/31709222.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0102","300110","BK0239"],"gpt_icon":0},{"id":"2575284031","title":"股市必读:10月13日华仁药业发布公告,股东减持328.76万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2575284031","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575284031?lang=zh_cn&edition=full","pubTime":"2025-10-14 02:43","pubTimestamp":1760380990,"startTime":"0","endTime":"0","summary":"截至2025年10月13日收盘,华仁药业报收于3.22元,下跌0.92%,换手率1.75%,成交量20.68万手,成交额6596.58万元。股本股东变化股东增减持10月13日华仁药业发布公告《华仁药业:关于股东减持计划实施完成的公告》,其股东红塔创新投资股份有限公司于2025年9月9日至2025年10月10日间合计减持328.76万股,占公司目前总股本的0.2781%,变动期间该股股价下跌4.13%,截止10月10日收盘报3.25元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101400027511.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0102","BK0239"],"gpt_icon":0},{"id":"2575409478","title":"华仁药业:大股东西安曲江天授质押118,221,298股","url":"https://stock-news.laohu8.com/highlight/detail?id=2575409478","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575409478?lang=zh_cn&edition=full","pubTime":"2025-10-13 20:53","pubTimestamp":1760359985,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)10月13日在投资者关系平台上答复投资者关心的问题。投资者提问:请问董秘,大股东西安曲江天授大健康投资合伙企业目前质押华仁药业的股数还有多少,这些质押股票是否出借,被用于做空?华仁药业回复:尊敬的投资者您好,公司控股股东西安曲江天授大健康投资合伙企业(有限合伙)目前质押华仁药业的股数为118,221,298股,不存在出借股票被用于做空的情况。感谢您的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300023563.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","300110"],"gpt_icon":0},{"id":"2571330308","title":"华仁药业(300110)披露补选第八届董事会非独立董事议案,9月29日股价上涨0.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2571330308","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571330308?lang=zh_cn&edition=full","pubTime":"2025-09-29 22:49","pubTimestamp":1759157353,"startTime":"0","endTime":"0","summary":"截至2025年9月29日收盘,华仁药业报收于3.23元,较前一交易日上涨0.62%,最新总市值为38.19亿元。该股当日开盘3.2元,最高3.24元,最低3.15元,成交额达5751.74万元,换手率为1.52%。本次会议将审议《关于补选第八届董事会非独立董事的议案》,并对中小投资者表决结果单独计票披露。本次会议仅有一项提案,投票代码为350110,投票简称为“华仁投票”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900035873.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300110","BK0102"],"gpt_icon":0},{"id":"2571856413","title":"华仁药业(300110.SZ)参与京津冀“3+N”联盟部分西药和中成药带量联动接续采购中选","url":"https://stock-news.laohu8.com/highlight/detail?id=2571856413","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571856413?lang=zh_cn&edition=full","pubTime":"2025-09-29 17:11","pubTimestamp":1759137109,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华仁药业 发布公告,公司及公司全资子公司广西裕源药业有限公司、华仁药业(日照)有限公司近期积极参与了京津冀“3+N”联盟部分西药和中成药带量联动接续采购的投标工作。根据天津市医药采购中心近日公布的中选结果,公司及全资子公司产品混合糖电解质注射液、盐酸倍他司汀氯化钠注射液及羟乙基淀粉130/0.4氯化钠注射液中选本次带量联动接续采购。本次中选产品2024年合计销售收入为1303.89万元,占公司2024年营业收入总额的0.96%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1350634.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0102","300110","BK0239"],"gpt_icon":0},{"id":"2568749962","title":"华仁药业:截至2025年9月10日股东总户数约为4.11万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2568749962","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568749962?lang=zh_cn&edition=full","pubTime":"2025-09-17 20:51","pubTimestamp":1758113489,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)09月16日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止目前,股东人数为多少?华仁药业回复:尊敬的投资者您好,截至2025年9月10日,公司股东总户数约为4.11万户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091700038230.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","300110"],"gpt_icon":0},{"id":"2566169092","title":"9月9日华仁药业发布公告,股东减持853.24万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2566169092","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566169092?lang=zh_cn&edition=full","pubTime":"2025-09-09 21:01","pubTimestamp":1757422865,"startTime":"0","endTime":"0","summary":"证券之星消息,9月9日华仁药业发布公告《华仁药业:简式权益变动报告书(红塔创新)》,其股东红塔创新投资股份有限公司于2025年8月26日至2025年9月8日间合计减持853.24万股,占公司目前总股本的0.7217%,变动期间该股股价下跌5.83%,截止9月8日收盘报3.39元。股东增减持详情见下表:根据华仁药业2025年中报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090900036388.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300110","BK0102"],"gpt_icon":0},{"id":"2564814116","title":"华仁药业最新公告:全资子公司安徽恒星制药盐酸奈福泮原料药获得上市申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2564814116","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564814116?lang=zh_cn&edition=full","pubTime":"2025-09-01 19:50","pubTimestamp":1756727422,"startTime":"0","endTime":"0","summary":"华仁药业(300110.SZ)公告称,公司全资子公司安徽恒星制药收到国家药品监督管理局核准签发的“盐酸奈福泮”《化学原料药上市申请批准通知书》。盐酸奈福泮为非麻醉性、非成瘾性强力镇痛药,临床主要对症治疗急性疼痛,尤其是术后疼痛。该原料药获得上市申请批准通知书,将进一步丰富公司原料药产品线,提升市场竞争力,并助力公司原料药、制剂、医疗器械、医用包材等板块的全面协同发展。但相关产品未来销售情况及对公司未来业绩的影响具有不确定性。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090100030575.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","01477","BK1574","300110","BK0239","BK0102"],"gpt_icon":0},{"id":"2562731925","title":"华仁药业:董事长张力受监视居住 已推举董事侯瑞鹏代行职责","url":"https://stock-news.laohu8.com/highlight/detail?id=2562731925","media":"金融界","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562731925?lang=zh_cn&edition=full","pubTime":"2025-08-26 21:13","pubTimestamp":1756214022,"startTime":"0","endTime":"0","summary":"华仁药业(300110.SZ)公告称,公司董事会于近日收到公司董事长张力先生的辞职报告,张力先生因个人原因申请辞去公司第八届董事会董事长、法定代表人等相关职务。公司于近日收到周至县公安局《监视居住决定书》,上述事项系针对公司董事长张力个人,与公司及相关业务无任何关联。董事长张力因个人原因申请辞去董事长、法定代表人等职务,与公司业务无关。公司已推举董事侯瑞鹏代行董事长职责,并计划尽快完成董事长的补选工作。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/26211352715171.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0102","BK0239","300110"],"gpt_icon":0},{"id":"2561472318","title":"华仁药业:截至2025年8月20日股东总户数约为4.10万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2561472318","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561472318?lang=zh_cn&edition=full","pubTime":"2025-08-22 20:51","pubTimestamp":1755867090,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)08月21日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止2025年8月20日,公司股东人数多少?华仁药业回复:尊敬的投资者您好,截至2025年8月20日,公司股东总户数约为4.10万户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082200042115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","300110"],"gpt_icon":0},{"id":"2560926964","title":"华仁药业(300110)2025年中报简析:净利润减49.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560926964","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560926964?lang=zh_cn&edition=full","pubTime":"2025-08-17 06:05","pubTimestamp":1755381929,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期华仁药业发布2025年中报。根据财报显示,华仁药业净利润减49.01%。截至本报告期末,公司营业总收入6.24亿元,同比下降19.13%,归母净利润3733.29万元,同比下降49.01%。按单季度数据看,第二季度营业总收入3.2亿元,同比下降12.15%,第二季度归母净利润2130.44万元,同比下降4.85%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081700001172.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110"],"gpt_icon":0},{"id":"2558642100","title":"华仁药业:截至8月10日股东总户数约为4.15万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2558642100","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558642100?lang=zh_cn&edition=full","pubTime":"2025-08-12 20:52","pubTimestamp":1755003124,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)08月11日在投资者关系平台上答复投资者关心的问题。投资者提问:请问董秘:截止8月10日,股东人数是多少?华仁药业回复:尊敬的投资者您好,截至2025年8月10日,公司股东总户数约为4.15万户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081200037787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0102","BK0239"],"gpt_icon":0},{"id":"2557727503","title":"华仁药业:截至2025年7月31日股东总户数约为4.24万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2557727503","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557727503?lang=zh_cn&edition=full","pubTime":"2025-08-06 20:52","pubTimestamp":1754484743,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)08月06日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止2025年7月31日,公司股东人数多少?华仁药业回复:尊敬的投资者您好,截至2025年7月31日,公司股东总户数约为4.24万户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080600036434.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300110","BK0239","BK0102"],"gpt_icon":0},{"id":"2556822759","title":"华仁药业最新公告:持股5%以上股东红塔创新计划减持不超过1%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2556822759","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556822759?lang=zh_cn&edition=full","pubTime":"2025-08-03 16:10","pubTimestamp":1754208646,"startTime":"0","endTime":"0","summary":"华仁药业(300110.SZ)公告称,公司收到持股5%以上股东红塔创新的减持计划告知函,红塔创新计划自公告之日起十五个交易日后的三个月内,通过集中竞价交易方式减持不超过公司总股本1%的股份,即不超过11,820,000股。减持原因为自身经营需要,股份来源为公司首次公开发行股票前其持有的股份。红塔创新不属于公司控股股东、实际控制人,本次减持计划实施不会导致公司控制权发生变化。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080300003118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300110","BK0102"],"gpt_icon":0},{"id":"2555833721","title":"华仁药业:截至7月20日股东总户数约为4.16万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2555833721","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555833721?lang=zh_cn&edition=full","pubTime":"2025-07-31 20:51","pubTimestamp":1753966303,"startTime":"0","endTime":"0","summary":"证券之星消息,华仁药业(300110)07月30日在投资者关系平台上答复投资者关心的问题。投资者提问:请问董秘,截止7月20日公司股东户数是多少?华仁药业回复:尊敬的投资者您好,截至2025年7月20日,公司股东总户数约为4.16万户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025073100035871.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","300110"],"gpt_icon":0},{"id":"2555016851","title":"华仁药业(300110.SZ)子公司取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2555016851","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555016851?lang=zh_cn&edition=full","pubTime":"2025-07-30 16:17","pubTimestamp":1753863441,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华仁药业(300110.SZ)公告,公司全资子公司青岛华仁医疗用品有限公司收到山东省药品监督管理局核准签发的“一次性使用腹透置管手术包”的《医疗器械注册证》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1323600.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","09996","BK0102","BK1100","BK1222","159883","BK1583","09997","BK1574","300110"],"gpt_icon":0},{"id":"2551123941","title":"7月16日华仁药业发布公告,股东减持1018.48万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2551123941","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551123941?lang=zh_cn&edition=full","pubTime":"2025-07-16 21:00","pubTimestamp":1752670859,"startTime":"0","endTime":"0","summary":"证券之星消息,7月16日华仁药业发布公告《华仁药业:关于持股5%以上股东减持计划实施完成的公告》,其股东华仁世纪集团有限公司于2025年7月9日至2025年7月16日间合计减持1018.48万股,占公司目前总股本的0.8615%,变动期间该股股价上涨1.78%,截止7月16日收盘报3.43元。股东增减持详情见下表:根据华仁药业2025年一季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071600036521.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","300110"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1761924497126,"stockEarnings":[{"period":"1week","weight":-0.0264},{"period":"1month","weight":0.0215},{"period":"3month","weight":-0.0929},{"period":"6month","weight":0.1448},{"period":"1year","weight":-0.0978},{"period":"ytd","weight":-0.0568}],"compareEarnings":[{"period":"1week","weight":0.0164},{"period":"1month","weight":0.0268},{"period":"3month","weight":0.1199},{"period":"6month","weight":0.2159},{"period":"1year","weight":0.2206},{"period":"ytd","weight":0.1895}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华仁药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"41100人(较上一季度增加0.98%)","perCapita":"28731股","listingDate":"2010-08-25","address":"山东省青岛市崂山区高科技工业园株洲路187号","registeredCapital":"118221万元","survey":" 华仁药业股份有限公司的主营业务是医药、医疗器械、医用包材、大健康、医药商业流通。公司的主要产品是基础输液、治疗制剂、腹透液、医疗器械、其他。公司是山东省应急储备定点输液生产企业,先后获得“全国AAA级信用企业”“国家知识产权优势/示范企业”“中国化学制药行业工业企业综合实力百强”“中国医药工业百强”“山东省质量管理奖”“山东省高端品牌培育企业”“‘品质鲁药’建设示范企业”等系列荣誉。","listedPrice":13.99},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.5","shortVersion":"4.35.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华仁药业(300110)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华仁药业(300110)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华仁药业,300110,华仁药业股票,华仁药业股票老虎,华仁药业股票老虎国际,华仁药业行情,华仁药业股票行情,华仁药业股价,华仁药业股市,华仁药业股票价格,华仁药业股票交易,华仁药业股票购买,华仁药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华仁药业(300110)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华仁药业(300110)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}